Læknaneminn - 01.10.1996, Qupperneq 39

Meðferð gigtsjúkdóma: Fyrri hluti
HEIMILDIR:
1. Jónsson H, Valtýsdóttir S Th, Kjartansson O, Brekkan A.
Hypermobility associated with osteoarthritis of the thumb base: A
clinical and radiological subset of hand osteoarthritis. Ann. Rheum.
Dis. 1996; 55: 540-43.
2. Felson DT. The epidemiology of knee osteoarthritis: Results from
the Framingham study. Semin Arthr Rheum 1990; 20 (suppl 1):
42-50.
3. Verbrugge LM, Gates DM, Ike RW. Risk factors for disability am-
ong US adults with arthritis. J Clin Epidemiol 1991; 44: 167-82.
4. Felson DT, Zhang Y, Anthony JM et al: Weight loss reduces the risk
for symptomatic knee osteoarthritis in women. Ann Intern Med
1992; 116: 535-39.
5. Kovar PA, Allegrante JP, Mackenzie CR. Supervised fitness walking
in patients with OA of the knee. Ann Int Med 1992; 116:529-34.
6. Pendergast DR, Kame VD Jr, Rouse L o.fl. Quantitative evaluation
of a physical therapy supervised home exercise program on muscle
and functional capacity of patients with osteoarthritis (abstrakt).
Arch Phys Med Rehabil. 1991; 72:792.
7. Clinical evaluation of the treatment of oa of the knee using a newly
designed wedge insole. Clin Orthop. 1987; 221: 181-87
8. Liang MH og Fortin P. Management of osteoarthritis of the hip
and knee NEJM 1991; 325:125-27.
9. Palmosni MJ, Brandt KD. In vivo effects of aspirin on canine osteo-
arthritic cartilage. Arthr. Rheum. 1983; 26: 994 -1001.
10. Bradley JD, Brandt KD, Katz BP o.fl. Comparison of an antiin-
flammatory dose of ibufen, an analgesic dose of ibufen and acetam-
inophen in the treatment of patients with osteoarthritis of the knee.
NEJM 1991;325:87-91.
11. Brooks PM, Potter SR, Buchanan WW. NSAID and osteoarthritis
- help or hindrance? J Rheumatol 1982; 9:3-5
12. Sandler DP, Smith JC, Weinberg CR o.fl. Analgesic use and chron-
ic renal disease. NEJM 1989; 320: 1238-1243.
13. Eriksson LO, Sturfelt G, Thysell H og Wollheim FA. Effects of su-
lindac and naproxen on prostaglandin excretion in patients with
impaired renal function and rheumatoid arthritis. Am.J.Med.
1990; 89: 313-321.
14. Green JM, Winickoff RN. Cost conscious prescribing of nonsteroi-
dal anti-inflammatory drugs for adults with arthritis: A review and
suggestions. 1992. Arch Int. Med; 152: 1995-2002).
15. Brooks PM og Day RO. Nonsteroidal antiinflammatory drugs -
differences and similarities. NEJM. 1991; 324: 1716-25.
16. Roth SH. Upper gastrointestinal safety with nabumetone. J.
Rheumatol. 1992; 19 (suppl 36): 74 - 9.
17. Huskisson EC, Woolf DL, Balme HW o.fl. Four new anti-in-
flammatory drugs: Responses and variations. Brit Med J. 1976; 1:
1048-1049
18. Sanders PA, Grennan DM. Non-steroidal anti-inflammatory drugs
versus simple analgesics in the treatment of arthritis. Balliere's Clin
Rheum. 1990; 4(2): 371-385.
19. GrifFin MR, Piper JM, Daugherty JR, Snowden M og Ray WA.
Nonsteroidal antiinflammatory drug use and increased risk for pept-
ic ulcer disease in elderly persons. Ann Intern Med. 1991; 114:
257-263.
20. Jorde R og Burhol PG. Asymptomatic peptic ulcer disease. Scand
J Gastroent. 1987; 22: 129-134.
21. Armstrong CP og Blower AL. Non-steroidal anti-inflammatroy
drugs and life threatening complications of peptic ulceration. Gut
1987; 28:527-532.
22. Hochberg MC, Altman RD, Brandt KD o.fl. Guidelines for the
medical management of osteoarthritis. Arthr.Rheum. 1995; 38:
1535-40.
23. Lichtenstein DR, Syngal S og Wolfe MM. Nonsteroidal antiin-
flammatory drugs and the gastrointestinal tract. Arthr. Rheum.
1995; 38: 5-18.
24. Gonzales GR og Portenoy RR. Selection of analgesic therapies in
rheumatoid arthritis: The role of opioid medications. Arthr.Care
Res. 1993;6:223-28.
25. Hollander JL. Intraarticular hydrocortisone in arthritis and allied
condition. J Bone Joint Surg. 1953; 35A: 983-87.
26. Friedman DM and Moore MA. The efficacy of intraarticular cort-
icosteroids for osteoarthritis of the knee. Arthr Rheum. 1978; 21:
556-61.
27. Zachariae L. Deleterious effects of corticosteroid administered top-
ically, in particular intra-articularily. Acta Orthop Scand. 1965;
36:127-31.
28. Gray RG, Gottlieb NL. Intra-articular corticosteroids. Clin Ort-
hop. 1983; 177: 235.
29. Traut EF. Procaine and procaine amide hydrochloride in skeletal
pain. JAMA 1952; 150: 785.
30. Jones A, Regan M, Ledingham J, Pattrick M, Manhire A og Doher-
ty M. Importance of placement of intra-articular steroid injections.
Brit J Med. 1993; 307: 1329 - 1330.
31. Harris WH og Sledge CB. Total hip and total knee replacement.
NEJM. 1990;323:801-07.
32. Sheon RP, Moskowitz RN og Goldberg VM. Soft tissue rheumatic
pain. 1996; 3ja útgáfa, Williams & Wilkins.
33. Rachlin ES. Myofascial pain and fibromyalgia. 1994; 1. Utgáfa,
Mosby - Year Book.
34. Steinbrocker O, Neustadt DH. Aspiration and injection therapy in
musculoskeletal disorders. 1972; Harper & Row.
35. Price R, Sinclair H, Heinrich I o.fl. Local injection treatment of
tennis elbow: Hydrocortisone, triamcinolone and lidocaine com-
pared. Br. J. Rheum. 1991; 30: 39-44.
36. Kapetanos G. The effect of the local corticosteroids on the healing
and biomechanical properties of the partially injured tendon. Clin
Orthop. Res. 1982; 163: 170-79.
37. Wolfe F, Smythe HA, Yunus MB et al. The American College of
Rheumatology 1990 criteria for the classification of fibromyalgia.
Arthr Rheum 1990; 33: 160-72.
38. Birgisson H, Jónsson H og Geirsson A, óbirt.
39. Goldenberg DL. Psychological symptoms and psychiatric diagnos-
is in patients with fibromyalgia. J Rheumatol (suppl 19) 1989; 16:
127-30.
40. Yunus MB, Ahles TA, Aldag JC, Masi AT. Relationship of clinical
features with psychological status in primary fibromyalgia. Arthr
Rheum 1991; 34: 15-21.
41. McCain GA, Bell DA, Mai F o.fl. A controlled study of the effects
of a supervised cardiovascular fitness training program on the man-
ifestations of the primary fibromyalgia syndrome. Arthr. Rheum.
1988; 31: 1135-41.
42. Goldenberg DL, Felson DT, Dinerman H. A randomized, con-
trolled trial of amitryptiline and naproxen in the treatment of pati-
ents with fibromyalgia. Arthr. Rheum. 1986; 29: 1371-77.
43. Kippel JH og Dieppe PA. Rhenmatolagy 1. útgáfa 1994.
44. Spilberg I et al: Colchicine and pseudogout. Arthr and Rheum
1980; 23:1062-63.
45. AllowayJA, Moriarty MJ, Hoogland YT og Nashel DJ. Compari-
son of triamcinolone acetonide with indomethacin in the treatment
of acute gouty arthritis. J. Rheumatol. 1993; 20: 111-13.
46. Groff GD, Franch WA, Raddaty DA. Systemic steroid therapy
foracute gout: A clinical trial and review of the literature. Sem. Art-
hr Rheum 1990; 19:329-36.
47. Gutman AB. Treatment of primary gout: The present status. Art-
hr. Rheum. 1965;8:911-20.
48. Wallace LS, Singer JZ. Therapy in gout. Rheum Dis Clin North
Am . 1988; 14: 441-457.
49. Tasatabai MR, Cummings NA. Intravenous colchicine in the treat-
ment of acute pseudogout. Arthr. Rheum. 1980; 23: 370-74.
50. Wallace SL og Singer JC. Review: Systemic toxicity associated with
the intravenous administration of colchicine- guidelines for use. J.
Rheumatol. 1988; 15:495-99.
LÆKNANEMINN
33
2. tbl. 1996, 49. árg.